Mirtazapine 45 MG Oral Tablet
1 INDICATIONS AND USAGE Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. (1)
Sun Pharmaceutical Industries, Inc.
OVAL WHITE 501
501 OVAL WHITE
Related Pills
mirtazapine 30 mg
sun pharmaceutical industries, inc.
Mirtazapine 45 MG Oral Tablet
Sun Pharmaceutical Industries, Inc.
mirtazapine tablet
sun pharmaceutical industries, inc.
Hydroxyzine Hydrochloride 25 mg
heritage pharmaceuticals inc.
Phenobarbital 32.4 MG Oral Tablet
Qualitest Pharmaceuticals
Hydroxyzine Hydrochloride 25 mg
Heritage Pharmaceuticals Inc.
Omeprazole 20 MG Sodium Bicarbonate 1100 MG Oral Capsule
Cadila Healthcare Limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
MIRTAZAPINE tablets, USP are supplied as: Tablet Strength Tablet Color/Shape Tablet Markings Package Configuration NDC Code 7.5 mg yellow, circular, biconvex tablet film coated tablets with “C” debossed on one side and plain on the other side Bottle / 30 count NDC 57664-510-83 15 mg yellow, oval, biconvex tablet film coated tablets with “499” debossed on one side and scored on the other side Bottle / 30 count NDC 57664-499-83 Bottle / 1000 count NDC 57664-499-18 30 mg Reddish-brown, oval, biconvex tablet film coated tablets with “500” debossed on one side and scored on the other side Bottle / 30 count NDC 57664-500-83 Bottle / 1000 count NDC 57664-500-18 45 mg white to off-white, oval, biconvex tablet film coated tablets with “501” debossed on one side and plain on the other side Bottle / 30 count NDC 57664-501-83 Bottle / 1000 count NDC 57664-501-18 Storage Store at 20° to 25°C (68° to 77°F); excursions permitted 15° to 30°C (59° to 86°F). [see USP Controlled Room Temperature]. Protect from light and moisture.
More pills like OVAL 501